Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aeterna Zentaris Inc (AEZS.TO)

Aeterna Zentaris Inc (AEZS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 14,313
  • Shares Outstanding, K 1,214
  • Annual Sales, $ 4,498 K
  • Annual Income, $ -16,552 K
  • 60-Month Beta 1.43
  • Price/Sales 2.28
  • Price/Cash Flow N/A
  • Price/Book 0.58
Trade AEZS.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -13.64
  • Most Recent Earnings $-4.64 on 03/27/24
  • Latest Earnings Date 05/14/24
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend 4,949.990 on 08/11/99
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.40 +11.06%
on 04/30/24
11.98 -3.59%
on 05/16/24
+0.75 (+6.94%)
since 04/16/24
3-Month
9.16 +26.09%
on 02/22/24
12.72 -9.20%
on 03/12/24
+1.87 (+19.32%)
since 02/16/24
52-Week
7.64 +51.18%
on 11/01/23
16.92 -31.74%
on 07/21/23
-3.37 (-22.59%)
since 05/16/23

Most Recent Stories

More News
Aeterna Zentaris: Q1 Earnings Snapshot

Aeterna Zentaris: Q1 Earnings Snapshot

AEZS.TO : 11.55 (-2.04%)
Aeterna Zentaris: Q4 Earnings Snapshot

Aeterna Zentaris: Q4 Earnings Snapshot

AEZS.TO : 11.55 (-2.04%)
Shortened Week Due to Easter Holiday

Monday U.S. Economic Lookahead New home sales (Feb.) Featured Earnings PVH Corp. (NYSE: ...

NOVC.TO : 1.23 (unch)
ANRG.TO : 0.2950 (+1.72%)
AEZS.TO : 11.55 (-2.04%)
PVH : 116.38 (-0.17%)
RPHM : 1.6600 (+3.75%)
MKC : 74.48 (-0.20%)
GME : 27.67 (-30.04%)
PRGS : 51.70 (+0.52%)
CTAS : 691.38 (-0.15%)
PAYX : 125.19 (+0.66%)
CCL : 14.90 (+0.27%)
WBA : 18.34 (+2.52%)
Aeterna Zentaris: Q3 Earnings Snapshot

Aeterna Zentaris: Q3 Earnings Snapshot

AEZS.TO : 11.55 (-2.04%)
Stocks in play: Aeterna Zentaris Inc.

Announced that Dr. Klaus Paulini, Chief Executive Officer of Aeterna, will present at the H.C. Wainwright ...

AEZS.TO : 11.55 (-2.04%)
Aeterna Zentaris: Q2 Earnings Snapshot

Aeterna Zentaris: Q2 Earnings Snapshot

AEZS.TO : 11.55 (-2.04%)
Aeterna Zentaris: Q1 Earnings Snapshot

Aeterna Zentaris: Q1 Earnings Snapshot

AEZS.TO : 11.55 (-2.04%)
Stocks in play: AEterna Zentaris Inc

Announced that sales of Macrilen® will be temporarily discontinued in the United States commercial market ...

AEZS.TO : 11.55 (-2.04%)
Aeterna Zentaris: Q4 Earnings Snapshot

Aeterna Zentaris: Q4 Earnings Snapshot

AEZS.TO : 11.55 (-2.04%)
Aeterna Zentaris: Q3 Earnings Snapshot

Aeterna Zentaris: Q3 Earnings Snapshot

AEZS.TO : 11.55 (-2.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement...

See More

Key Turning Points

3rd Resistance Point 12.27
2nd Resistance Point 12.12
1st Resistance Point 11.84
Last Price 11.55
1st Support Level 11.41
2nd Support Level 11.26
3rd Support Level 10.98

See More

52-Week High 16.92
Fibonacci 61.8% 13.38
Fibonacci 50% 12.28
Last Price 11.55
Fibonacci 38.2% 11.18
52-Week Low 7.64

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar